Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Differential CSF biomarker levels in APOE-epsilon4-positive and -negative patients with memory impairment.

Dementia and geriatric cognitive disorders - 1 Jan 2007

Andersson Christin, Blennow Kaj, Johansson Sven-Erik, Almkvist Ove, Engfeldt Peter, Lindau Maria, Eriksdotter-Jönhagen Maria

Abstract excerpt

OBJECTIVES: To investigate the relationships between episodic memory, APOE genotype, CSF markers (total tau, T-tau; phospho-tau, P-tau; beta-amyloid, Abeta42) and longitudinal cognitive decline. METHODS: 124 memory clinic patients were retrospectively divided into 6 groups based on (i) episodic memory function (Rey Auditory Verbal Learning Test, RAVLT): severe, moderate or no impairment (SIM, MIM or NIM), and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amyloid beta-Protein Precursor
Share to Apolipoprotein E4

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Apolipoproteins E

Share to Cognition Disorders

Share to Memory Disorders

Share to Neuropsychological Tests

Share to Severity of Illness Index

Share to tau Proteins

Source

Identifiers

PMID: 17124416
DOI: 10.1159/000097354

Genes

APOE

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Differential CSF biomarker levels in APOE-epsilon4-positive and -negative patients with memory impairment.PMID 17124416Read ↗

APOE-epsilon4 is associated with memory decline in cognitively impaired elderly.Semantic proximity Read ↗

Apolipoprotein E (APOE) genotype has dissociable effects on memory and attentional-executive network function in Alzheimer's disease.Semantic proximity Read ↗

Preclinical memory profile in Alzheimer patients with and without allele APOE-epsilon4.Semantic proximity Read ↗

Rapid progression from mild cognitive impairment to Alzheimer's disease in subjects with elevated levels of tau in cerebrospinal fluid and the APOE epsilon4/epsilon4 genotype.Semantic proximity Read ↗

CSF Abeta42, Tau and phosphorylated Tau, APOE epsilon4 allele and MCI type in progressive MCI.Semantic proximity Read ↗

Apolipoprotein epsilon4 allele status, depressive symptoms, and cognitive decline in middle-aged and elderly persons without dementia.Semantic proximity Read ↗

Longitudinal Modeling of Age-Related Memory Decline and the<i>APOE</i>ε4 EffectSemantic proximity Read ↗

Apolipoprotein E epsilon 4 allele in association with global cognitive performance and CSF markers in Alzheimer's disease.Semantic proximity Read ↗

APOE effect on Alzheimer's disease biomarkers in older adults with significant memory concern.Semantic proximity Read ↗

Accelerated memory decline in Alzheimer's disease with apolipoprotein epsilon4 allele.Semantic proximity Read ↗

Episodic memory changes are associated with the APOE-epsilon 4 allele in nondemented older adults.Semantic proximity Read ↗

Neuropsychological function and apolipoprotein E genotype in the preclinical detection of Alzheimer's disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.